Clinical Trial Update: A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial in pediatric patients investigating tranexamic acid for thrombocytopenia has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Coagulation Defect
• Hemostatic Disorder
• Thrombocytopenia

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Meghan McCormick | Conditions: Pediatric Cancer, Thrombocytopenia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-09-20